Evidence map›Paper›PMID 42290236›Full record

ArticleEuropean journal of public health2026

Identifying barriers and policy priorities for rare disease research in underrepresented European countries.

Baiba Lace, Inna Inashkina, Dorica Dan, Ariane Weinman, Pauline Adam, Oleg Kvlividze, Birute Tumiene, Anabela Isidro, Carlos Almeida Pereira, Gonçalo Teixeira and 2 more

Abstract read
In one paragraph

Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Baiba LaceDepartment of Genetics, Riga East University hospital, University of Latvia, Riga, Latvia.ORCID 0000-0001-5371-6756
Inna InashkinaCentre of Pathology, Riga East University hospital, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Dorica DanEURORDIS, Paris, France.
Ariane WeinmanEURORDIS, Paris, France.
Pauline AdamINSERM, Paris, France.
Oleg KvlividzeGeorgian Foundation for Genetic and Rare Diseases, Tbilisi, Georgia.
Birute TumieneFaculty of Medicine, Vilnius University, Vilnius, Lithuania.
Anabela IsidroAgency for Clinical Research and Biomedical Innovation (AICIB), Porto, Portugal.
Carlos Almeida PereiraAgency for Clinical Research and Biomedical Innovation (AICIB), Porto, Portugal.
Gonçalo TeixeiraAgency for Clinical Research and Biomedical Innovation (AICIB), Porto, Portugal.
Rachel K CrowleyRare Disease Clinical Trial Network, University College Dublin (UCD), Dublin, Ireland.
ERDERA UC Stakeholder Panel

Funding

European Union under the Horizon Europe programme 101156595-ERDERA
6 · The paper itself

Abstract

The European Joint Programme on Rare Diseases successfully advanced rare disease research and also revealed challenges for underrepresented countries, those less frequently holding or leading grants. This study aimed to survey Rare Disease researchers in these countries, identify barriers to participation in research, and propose solutions. A modified Delphi approach without formal consensus thresholds of 186 respondents highlighted fragmented or outdated policies and heterogeneous funding. Nearly all participants prioritized the need for EU-wide policies defining minimum quality standards for Rare Disease care. Key priorities include access to genetic testing and essential services to support uniform care and shared research capacity.

Indexed as

Biomedical ResearchHealth PolicyRare DiseasesDelphi TechniqueEuropeHumans

Identifiers

PMID42290236
PMCPMC13265805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.